Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) ...

Omalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food ...

The study of success eating food triggers after stopping Xolair is ongoing, so researchers are still collecting data for doctors to use making treatment plans with their patients. Parents interested ...

Infants exclusively breastfed in the first 3 days of life had fewer food allergies at 1 year of age than those who also got ...

Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children ...

Omalizumab works by binding to the allergy-causing antibody called immunoglobulin E in the blood and preventing it from ...

Omalizumab was found to be more effective than multi-allergen oral immunotherapy (OIT) in reducing allergic reactions in patients with 1 or more food allergies, according to results from Stage 2 of ...

Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...

A new study has revealed that the injectable asthma drug helped more than one-third of the kids to overcome their food ...

Pharvaris (PHVS) highlighted safety and efficacy data of deucrictibant, which is currently being evaluated in two pivotal Phase 3 studies, ...